Abstract
Purpose
To assess the diagnostic performance of breast MRI for BI-RADS 4A microcalcifications on mammography and propose a potential clinical pathway to avoid unnecessary biopsies.
Methods
Bibliometrics analysis of breast MRI and BI-RADS 4 was provided. A retrospective analysis was conducted on 139 women and 142 cases of BI-RADS 4A microcalcifications on mammography from Fudan University Shanghai Cancer Center. The mammographic BI-RADS level and the MRI reports were compared with the final pathological diagnosis.
Results
Much attention has been given to breast MRI and BI-RADS 4 in the literature. However, studies on BI-RADS 4A are limited. Pathological results showed 117 cases (82.4%) were benign lesions, malignant cases of 25 (17.6%) in our study. The positive predictive values (PPV), specificity, sensitivity and negative predictive values (NPV) of MRI were 44.2% (23/52), 75.2% (88/117), 92.0% (23/25), and 97.8% (88/90), respectively. Therefore, 75.2% (88/117) of biopsies for benign lesions could potentially be avoided. There were 2.2% (2/90) malignant lesions missed. Logistic regression indicated that patients who are postmenopausal (HR = 2.655, p = 0.012), have a history of breast cancer (family history) (HR = 2.833, p = 0.029), and exhibit clustered microcalcifications (HR = 2.179, p = 0.046) are more likely to have a higher MRI BI-RADS level.
Conclusions
Breast MRI has the potential to improve the diagnosis of BI-RADS 4A microcalcifications on mammography. We propose a potential clinical pathway that patients with BI-RADS 4A on mammography who are premenopausal, have no personal history of breast cancer (family history) or have non-clustered distribution of calcifications can undergo MRI to avoid unnecessary biopsies.
Similar content being viewed by others
Data availability
The datasets generated during the current study are no publicly available due to protect study participant privacy but they are available from the corresponding author on reasonable request.
Abbreviations
- BI-RADS:
-
Breast Imaging and Reporting System
- DCIS:
-
Ductal carcinoma in situ
- DCIS-IM:
-
DCIS with microinvasion
- IDC:
-
Invasive ductal carcinoma
- MRI:
-
Breast magnetic resonance imaging
- NPV:
-
Negative predictive values
- PPV:
-
Positive predictive values
References
Wilkinson L, Thomas V, Sharma N (2017) Microcalcification on mammography: approaches to interpretation and biopsy. Br J Radiol 90(1069):20160594. https://doi.org/10.1259/bjr.20160594
Kang SS, Ko EY, Han BK, Shin JH (2008) Breast US in patients who had microcalcifications with low concern of malignancy on screening mammography. Eur J Radiol 67(2):285–291. https://doi.org/10.1016/j.ejrad.2007.06.018
Li S, Qu F, Yang Y, Wang L, Shen J, Shao Z (2020) Value of stereotactic 11-gauge vacuum-assisted breast biopsy in non-palpable suspicious calcifications: an eight-year single institution experience with 587 patients. Gland Surg 9(5):1258–1266. https://doi.org/10.21037/gs-20-456
Magny SJ, Shikhman R, Keppke AL (2022) Breast imaging reporting and data system. StatPearls Publishing
Bassett LW (1992) Mammographic analysis of calcifications. Radiol Clin North Am 30(1):93–105
Bennani-Baiti B, Bennani-Baiti N, Baltzer PA (2016) Diagnostic performance of breast magnetic resonance imaging in non-calcified equivocal breast findings: results from a systematic review and meta-analysis. PLoS ONE 11(8):e0160346. https://doi.org/10.1371/journal.pone.0160346
Bennani-Baiti B, Baltzer PA (2017) MR Imaging for diagnosis of malignancy in mammographic microcalcifications: a systematic review and meta-analysis. Radiology 283(3):692–701. https://doi.org/10.1148/radiol.2016161106
Gweon HM, Eun NL, Youk JH, Jeong J, Bae SJ, Ahn SG, Kim JA, Son EJ (2022) Added value of abbreviated breast magnetic resonance imaging for assessing suspicious microcalcification on screening mammography-a prospective study. Eur Radiol 32(2):815–821. https://doi.org/10.1007/s00330-021-08196-y
van Eck NJ, Waltman L (2010) Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics 84(2):523–538. https://doi.org/10.1007/s11192-009-0146-3
Mei H, Xu J, Yao G, Wang Y (2020) The diagnostic value of MRI for architectural distortion categorized as BI-RADS category 3–4 by mammography. Gland Surg 9(4):1008–1018. https://doi.org/10.21037/gs-20-505
Hu Q, Wang XY, Zhu SY, Kang LK, Xiao YJ, Zheng HY (2015) Meta-analysis of contrast-enhanced ultrasound for the differentiation of benign and malignant breast lesions. Acta Radiologica (Stockholm, Sweden: 1987) 56(1):25–33. https://doi.org/10.1177/0284185113517115
Chen C (2004) Searching for intellectual turning points: progressive knowledge domain visualization. Proc Natl Acad Sci USA 101(Suppl 1):5303–5310. https://doi.org/10.1073/pnas.0307513100
Synnestvedt MB, Chen C, Holmes JH (2005) CiteSpace II: visualization and knowledge discovery in bibliographic databases. AMIA … Annual Symposium proceedings. AMIA Symposium 2005:724–728
Bukar UA, Sayeed MS, Razak SFA, Yogarayan S, Amodu OA, Mahmood RAR (2023) A method for analyzing text using VOSviewer. MethodsX 11:102339. https://doi.org/10.1016/j.mex.2023.102339
Mann RM, Cho N, Moy L (2019) Breast MRI: state of the art. Radiology 292(3):520–536. https://doi.org/10.1148/radiol.2019182947
Woitek R, Spick C, Schernthaner M, Rudas M, Kapetas P, Bernathova M, Furtner J, Pinker K, Helbich TH, Baltzer PAT (2017) A simple classification system (the Tree flowchart) for breast MRI can reduce the number of unnecessary biopsies in MRI-only lesions. Eur Radiol 27(9):3799–3809. https://doi.org/10.1007/s00330-017-4755-6
Bakker MF, de Lange SV, Pijnappel RM, Mann RM, Peeters PHM, Monninkhof EM, Emaus MJ, Loo CE, Bisschops RHC, Lobbes MBI, de Jong MDF, Duvivier KM, Veltman J, Karssemeijer N, de Koning HJ, van Diest PJ, Mali WPTM, van den Bosch MAAJ, Veldhuis WB, van Gils CH, DENSE Trial Study Group (2019) Supplemental MRI screening for women with extremely dense breast tissue. N Engl J Med 381(22):2091–2102.https://doi.org/10.1056/NEJMoa1903986
Comstock CE, Gatsonis C, Newstead GM, Snyder BS, Gareen IF, Bergin JT, Rahbar H, Sung JS, Jacobs C, Harvey JA, Nicholson MH, Ward RC, Holt J, Prather A, Miller KD, Schnall MD, Kuhl CK (2020) Comparison of abbreviated breast MRI vs digital breast tomosynthesis for breast cancer detection among women with dense breasts undergoing screening. JAMA 323(8):746–756. https://doi.org/10.1001/jama.2020.0572
Baltzer PAT, Bennani-Baiti B, Stöttinger A, Bumberger A, Kapetas P, Clauser P (2018) Is breast MRI a helpful additional diagnostic test in suspicious mammographic microcalcifications? Magn Reson Imaging 46:70–74. https://doi.org/10.1016/j.mri.2017.10.012
Li E, Li J, Song Y, Xue M, Zhou C (2014) A comparative study of the diagnostic value of contrast-enhanced breast MR imaging and mammography on patients with BI-RADS 3–5 microcalcifications. PLoS ONE 9(11):e111217. https://doi.org/10.1371/journal.pone.0111217
Di Ninno AAM, Mello GGN, Torres US, Shimizu C, Tucunduva TCM, Reis FRS, Ananias MPF, Lederman HM (2021) MRI as a complementary tool for the assessment of suspicious mammographic calcifications: does it have a role? Clin Imaging 74:76–83. https://doi.org/10.1016/j.clinimag.2021.01.001
Erbas B, Provenzano E, Armes J, Gertig D (2006) The natural history of ductal carcinoma in situ of the breast: a review. Breast Cancer Res Treat 97(2):135–144. https://doi.org/10.1007/s10549-005-9101-z
Ren W, Chen M, Qiao Y, Zhao F (2022) Global guidelines for breast cancer screening: a systematic review. Breast (Edinburgh, Scotland) 64:85–99. https://doi.org/10.1016/j.breast.2022.04.003
Heller SL, Moy L (2019) MRI breast screening revisited. J Magn Reson Imaging 49(5):1212–1221. https://doi.org/10.1002/jmri.26547
Acknowledgements
We thank all patients for participating in the study.
Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Contributions
SPL, YHL and YLY drafted the manuscript. YLY designed study. SPL, YHL were responsible for data collection and statistical analysis. GYL, ZMS and YLY revised the manuscript and all authors agreed to be responsible for all aspects of the study. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflicts of Interest
The authors have no conflicts of interest.
Ethical Approval
Ethical approval was not provided for this study on human participants because as a retrospective cohort study, all the procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Written informed consent for participation was not required for this study in accordance with the national legislation and the institutional requirements.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Li, S., Lin, Y., Liu, G. et al. Unveiling the potential of breast MRI: a game changer for BI-RADS 4A microcalcifications. Breast Cancer Res Treat (2024). https://doi.org/10.1007/s10549-024-07320-y
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10549-024-07320-y